MAPT and Alzheimer disease: In contrast, AD pathology may affect vascular and endothelial function, which may contribute to the development of cerebral SVD and, potentially, to failure of eliminating abnormal neurotoxic proteins, such as Aβ and phosphorylated tau, from the brain (109).